Sunday - September 20, 2026

Category Archives: Science

Non-Cystic Fibrosis Bronchiectasis Pipeline: DelveInsight Highlights Major Advances, Transformative Therapies, and 12+ Leading Players Wheeling the Therapeutics Landscape

The Non-Cystic Fibrosis Bronchiectasis Clinical Trial analysis report delivers important insights into ongoing research of 12+ pipeline Non-Cystic Fibrosis Bronchiectasis Drugs, clinical strategies, upcoming therapeutics, and commercial analysis. (Albany, US) September 17, 2026 – DelveInsight’s “Non-Cystic Fibrosis Bronchiectasis Pipeline Insights … Continue reading →

Dystrophic Epidermolysis Bullosa Pipeline: Emerging Therapies and Key Developments Shaping the Treatment Landscape | DelveInsight

The Dystrophic Epidermolysis Bullosa clinical trial analysis report delivers important insights into ongoing research on 15+ pipeline Dystrophic Epidermolysis Bullosa drugs, clinical strategies, upcoming therapeutics, and commercial analysis. (Albany, US) September 17, 2026 – DelveInsight’s “Dystrophic Epidermolysis Bullosa Pipeline Insights … Continue reading →

Neurotrophic Keratitis Pipeline Gains Momentum: 3+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

The Neurotrophic Keratitis clinical trial analysis report delivers important insights into ongoing research of 3+ pipeline Neurotrophic Keratitis drugs, clinical strategies, upcoming therapeutics, and commercial analysis. (Albany, US) September 17, 2026 – DelveInsight’s “Neurotrophic Keratitis Pipeline Insights 2026” report provides … Continue reading →

Familial Chylomicronemia Syndrome Market Size, Share, Growth, Epidemiology and Forecast to 2036

DelveInsight’s latest report, “Familial Chylomicronemia Syndrome Market Insights, Epidemiology and Market Forecast – 2036,” provides a comprehensive assessment of the Familial Chylomicronemia Syndrome (FCS) market across the United States, EU4 (Germany, France, Italy, and Spain), the United Kingdom, and Japan. … Continue reading →

Bulimia Nervosa Market: Steady Growth Amid Rising Diagnosis Rates and a Stagnant Pharmacological Pipeline Through 2036

(Albany, New York) – 17th Sep 2026 – DelveInsight’s “Bulimia Nervosa Market Insights, Epidemiology, and Market Forecast – 2036” report delivers an in-depth understanding of bulimia nervosa, covering historical and forecasted epidemiology, current treatment practices, market trends, and the therapeutic landscape … Continue reading →

Bone Neoplasms Market: Steady Growth Driven by Rising Incidence and Advancing Precision Oncology Pipeline Through 2036

(Albany, New York) – 17th Sep 2026 – DelveInsight’s “Bone Neoplasms Market Insights, Epidemiology, and Market Forecast – 2036” report delivers an in-depth understanding of bone neoplasms, covering historical and forecasted epidemiology, current treatment practices, market trends, and emerging therapies across … Continue reading →

Creative Bioarray Launches Comprehensive iPSC Characterization Services to Enhance Stem Cell Research and Applications

Creative Bioarray is proud to announce the launch of its comprehensive iPSC characterization services which designed to provide researchers with critical tools needed for the validation, assessment, and application of iPSCs in diverse scientific domains including regenerative medicine, disease modeling, … Continue reading →